Q1 2021 Holdings
Filed 2021-05-18 | 58 holdings | $130.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $36.0M | 583,767 | 27.5% |
| Codexis Inc(CDXS) | COM | 192005106 | $32.0M | 1,400,000 | 24.5% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $20.3M | 985,000 | 15.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.5M | 580,000 | 10.3% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $12.1M | 2,112,918 | 9.3% |
| Acutus Medical Inc(AFIB) | COM | 005111109 | $8.2M | 614,990 | 6.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $5.3M | 576,000 | 4.1% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $2.9M | 188,000 | 2.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $106.3K | 6,480,000 | 0.1% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $43.3K | 4,490,000 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $40.3K | 2,558,472 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $29.6K | 4,040,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $21.2K | 666,200 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $20.7K | 2,518,371 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $20.7K | 3,065,416 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $17.9K | 437,500 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $17.0K | 2,526,500 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $15.1K | 1,225,000 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $13.7K | 3,875,000 | 0.0% |
| Gemini Therapeutics Inc | COM | 36870G105 | $11.0K | 810,500 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $10.0K | 222,000 | 0.0% |
| Seres Therapeutics(MCRB1EUR) | COM | 81750R102 | $9.8K | 300,000 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $9.7K | 157,500 | 0.0% |
| Checkpoint Therapeutics Inc(CKPTUSD) | COM | 162828107 | $9.2K | 2,925,963 | 0.0% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $8.6K | 1,303,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $8.3K | 284,050 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $8.0K | 1,670,600 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $7.9K | 2,600,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $7.8K | 341,950 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.7K | 297,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.5K | 467,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.1K | 357,800 | 0.0% |
| Sanara Medtech Inc(SMTI) | COM | 79957L100 | $7.0K | 225,000 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $6.3K | 1,250,000 | 0.0% |
| Aveo Biosciences Inc(0HJQ) | COM NEW | 053588307 | $6.1K | 835,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $5.9K | 320,926 | 0.0% |
| Verastem Inc | COM | 92337C104 | $5.7K | 2,325,000 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $5.4K | 365,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $5.3K | 1,556,000 | 0.0% |
| SIO Gene Therapies Inc | COM | 829399104 | $5.2K | 2,000,000 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $5.2K | 871,800 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $5.1K | 249,800 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.1K | 147,000 | 0.0% |
| Lumos Pharma Inc | COM | 55028X109 | $4.4K | 376,900 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $4.2K | 711,200 | 0.0% |
| Optinose Inc | COM | 68404V100 | $3.0K | 826,000 | 0.0% |
| Highcape Capital Acquisition Corp | COM CL A | 42984L105 | $2.9K | 241,300 | 0.0% |
| Edap TMS SA(EDA) | SPONSORED ADR | 268311107 | $2.9K | 341,300 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.6K | 151,139 | 0.0% |
| Biohaven Pharmaceutical Hldg(BHVN) | COM | G11196105 | $1.7K | 25,000 | 0.0% |